Gregory Weaver, Former EVP, CFO, & Director, Director at Atossa Therapeutics, holds 10.00K shares in Altimmune (Ticker: ALT), holds 55.00 shares in Atossa Therapeutics (Ticker: ATOS), holds 4.67K shares in ATAI Life Sciences (Ticker: ATAI). Most recently, Gregory Weaver Bought ― shares of Altimmune on Mar 14, 2025 for an estimated value of $51.90K.
Gregory Weaver latest transaction was an Informative Buy of $51.90K.
What was Gregory Weaver's most profitable transaction?
Gregory Weaver’s most profitable transaction was an Informative Sell of ATOS stock on July 7, 2021. The return on the trade was 80.70%.
What is Gregory Weaver's role in Atossa Therapeutics?
Gregory Weaver's role in Atossa Therapeutics is Former EVP, CFO, & Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.